Modulating effect of ginger extract on rats with ulcerative colitis

Journal of Ethnopharmacology

Volumn 118, Issue 3, 2008, Pages 367-372

  El Abhar, Hanan S ^a   Hammad, Lamiaa N A ^b   Gawad, Hala S Abdel ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b Al Azhar University   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Ginger extract; MPO; Oxidative stress; PGs; TNF ; Ulcerative colitis

Indexed keywords

ACETIC ACID; CATALASE; GINGER EXTRACT; GLUTATHIONE; MALONALDEHYDE; MYELOPEROXIDASE; PROSTAGLANDIN E2; SALAZOSULFAPYRIDINE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG ISOLATION; GINGER; HISTOPATHOLOGY; IMMUNOMODULATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RAT; RHIZOME; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; GINGER; LIPID PEROXIDATION; MALE; PEROXIDASE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SULFASALAZINE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; ZINGIBER OFFICINALE;

EID: 47749122128     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.04.026     Document Type: Article

References (45)

1. Aebi H. Catalase. In: Bergmeyer H.U. (Ed). Methods in Enzymatic Analysis vol. 3 (1983), Academic Press, New York 276-286
2. Akgun E., Caliskan C., Celik H.A., Ozutemiz A.O., Tuncyurek M., and Aydin H.H. Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats. Journal of International Medical Research 33 (2005) 196-206
3. Ardizzone S., and Bianchi P.G. Biologic therapy for inflammatory bowel disease. Drugs 65 (2005) 2253-2286
4. Bliddal H., Rosetzsky A., Schlichting P., Weidner M.S., Andersen L.A., Ibfelt H.H., Christensen K., Jensen O.N., and Barslev J. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 8 (2000) 9-12
5. Blomhoff R. Antioxidants and oxidative stress. Tidsskrift for den Norske Laegeforening 124 (2004) 1643-1645 (abstract)
6. Buffinton G.D., and Doe W.F. Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radical Biology and Medicine 19 (1995) 911-918
7. Cetinkaya A., Bulbuloglu E., Kantarceken B., Ciralik H., Kurutas E.B., Buyukbese M.A., and Gumusalan Y. Effects of l-carnitine on oxidant/antioxidant status in acetic acid-induced colitis. Digestive Diseases and Sciences 51 (2006) 488-494
8. Cetinkaya A., Bulbuloglu E., Kurutas E.B., Ciralik H., Kantarceken B., and Buyukbese M.A. Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. The Tohoku Journal of Experimental Medicine 206 (2005) 131-139
9. Chrubasik J.E., Roufogalis B.D., and Chrubasik S. Evidence of effectiveness of herbal anti-inflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytotherapy Research 21 (2007) 675-683
10. Dionne S., Hiscott J., D'Agata I., Duhaime A., and Seidman E.G. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Digestive Diseases and Sciences 42 (1997) 1557-1566
11. Dryden Jr. G.W., Deaciuc I., Arteel G., and McClain C.J. Clinical implications of oxidative stress and antioxidant therapy. Current Gastroenterology Reports 7 (2005) 308-316
12. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastro-enterology 115 (1998) 182-205
13. Frondoza C.G., Sohrabi A., Polotsky A., Phan P.V., Hungerford D.S., and Lindmark L. An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cellular and Developmental Biology Animal 40 (2004) 95-101
14. Ghayur M.N., and Gilani A.H. Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders. Digestive Diseases and Sciences 50 (2005) 1889-1897
15. Grzanna R., Lindmark L., and Frondoza C.G. Ginger-an herbal medicinal product with broad anti-inflammatory actions. Journal of Medicinal Food 8 (2005) 125-132
16. Jainu M., Mohan K., and Devi C. Protective effect of Cissus quadrangularis on neutrophil mediated tissue injury induced by aspirin in rats. Journal of Ethnopharmacology 104 (2006) 302-305
17. 2 production. Phytochemistry 66 (2005) 1614-1635
18. Joshi R., Kumar S., Unnikrishnan M., and Mukherjee T. Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radical Research 39 (2005) 1163-1172
19. Kozuch P.L., and Hanauer S. Treatment of inflammatory bowel disease: a review of medical therapy. World Journal of Gastroenterology 14 (2008) 354-377 (abstract)
20. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
21. Kruidenier L., Kuiper I., Lamers C., and Verspaget H.W. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. The Journal of Pathology 201 (2003) 28-36
22. Kruidenier L., and Verspaget H.W. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous?. Alimentary Pharmacology and Therapeutics 16 (2002) 1997-2015
23. Langner E., Greifenberg S., and Gruenwald J. Ginger: history and use. Advances in Therapy 15 (1998) 25-44
24. Lantz R.C., Chen G.J., Sarihan M., Sólyom A.M., Jolad S.D., and Timmermann B.N. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 14 (2007) 123-128
25. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186 (1990) 464-478
26. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126 (2004) 1504-1517
27. Lowry O.H., Rosenbrough M.S., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-267
28. Marklund S., and Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and convenient assay for superoxide dismutase. European Journal of Biochemistry 47 (1974) 69-74
29. Masuda Y., Kikuzaki H., Hisamoto M., and Nakatani N. Antioxidant properties of gingerol related compounds from ginger. Biofactors 21 (2004) 293-296
30. Millar A.D., Rampton D.S., Chander C.L., Claxson A.W.D., and Blake D.R. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease in a rat model of colitis. Gut 39 (1996) 407-415
31. Munakata W., Liu Q., Shimoyama T., Sawaya M., Umeda T., and Sugawara K. Ecabet sodium attenuates reactive oxygen species produced by neutrophils after priming with bacterial lipopolysaccharides. Luminescence 18 (2003) 330-333
32. Mustafa A., El-Medany A., Hagar H., and El-Medany G. Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacological Research 53 (2006) 324-330
33. Nakamura K., Honda K., Mizutani T., Akiho H., and Harada N. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. World Journal of Gastroenterology 12 (2006) 4628-4635
34. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95 (1979) 351-358
35. +-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-α. American Journal of Physiology, Gastrointestinal and Liver Physiology 290 (2006) G361-G368
36. Owens C.W.J., and Belcher R.V. A colorimetric micro method for determination of glutathione. Biochemical Journal 94 (1965) 705-711
37. Pronai L., Yukinobu I., Láng I., and Fehér J. The oxygen-centered radicals scavenging activity of sulfasalazine and its metabolites. A direct protection of the bowel. Acta Physiologica Hungarica 80 (1992) 317-323 (abstract)
38. Reinecker H.C., Steffen M., Witthoeft T., Pfl{ligature}ueger I., Schreibe S., and Mac-Dermatt R.P. Enhanced secretion of tumor necrosis factor-alpha, IL-6 and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clinical and Experimental Immunology 94 (1993) 174-181
39. Sartor R.B. Pathogenesis and immune mechanisms of chronic inflammatory bowel disease. The American Journal of Gastroenterology 92 (1997) 5S-11S
40. Shukla Y., and Singh M. Cancer preventive properties of ginger: a brief review. Food and Chemical Toxicology 45 (2007) 683-690
41. Stucchi A., Reed K., O'Brien M., Cerda S., Andrews C., Gower A., Bushell K., Amar S., Leeman S., and Becker J. A new transcription factor that regulates TNFalpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC. Inflammatory Bowel Disease 12 (2006) 581-587
42. Tripathi S., Maier K.G., Bruch D., and Kittur D.S. Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages. Journal of Surgical Research 138 (2007) 209-213
43. White B. Ginger: an overview. American Family Physician 75 (2007) 1689-1691
44. Young H.Y., Luo Y.L., Cheng H.Y., Hsieh W.C., Liao J.C., and Peng W.H. Analgesic and anti-inflammatory activities of [6]-gingerol. Journal of Ethnopharma-cology 96 (2005) 207-210
45. Zeeh J.M., Procaccino F., Hoffmann P., Aukerman S.L., McRoberts J.A., Soltani S., Pierce G.F., Lakshmanan J., Lacey D., and Eysselein V.E. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 110 (1996) 1077-1083